Health News Archive - May 19, 2010
AUSTIN, Texas, and TUCSON, Arizona, May 19 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc.
COLUMBIA, Md., May 19 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it intends to release the results of its second quarter of fiscal 2010 on June 3, 2010, at approximately 4:00 p.m. Eastern Time (ET). At 4:45 p.m.
RYE, N.Y., May 19 /PRNewswire/ -- Curemark, LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, has introduced a redesigned logo and launched a new Web site, the company announced.
HACKENSACK, N.J., May 19 /PRNewswire/ -- A Phase I clinical trial of SNS-032, one of the first in a new class of drugs that inhibit cyclin-dependent kinases, demonstrated the drug's safety and potential clinical action against advanced chronic lymphocytic leukemia (CLL).
When people are under chronic stress, they tend to smoke, drink, use drugs and overeat to help cope with stress.
TAU researcher develops tool to measure tissue damage in the bedridden and paralyzed.
ATLANTA, May 19 /PRNewswire/ -- In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes.
New NCPA Report Says Employer Penalties Will Negatively Affect Job Creation DALLAS, May 19 /PRNewswire-USNewswire/ -- Although the IRS announced yesterday the ground rules for small businesses eligible for a new federal tax credit, small business owners may be in for a big surprise.
The results may lead to new approach to therapies for joint disease.
When the forces of evolution took over an experimental strain of bacteria, it derailed an experiment Duke and NC State researchers thought they were conducting, but led to something much more profound instead.